By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish on PSUS, citing a lack of unique value proposition, persistent discount risk due to no buyback commitment, and uncertainty around Ackman's performance in a higher-rate regime.
Risk: Persistent NAV discount due to lack of buyback commitment and uncertainty around Ackman's performance in a higher-rate regime.
Opportunity: None identified.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Bill Ackman’s New IPO Was Supposed to Be a Big Deal. Now He’s Blaming Retail Investors as PSUS Stock Falls.
Oleksandr Pylypenko
7 min read
Bill Ackman’s latest venture into the public markets was supposed to be a big deal. The high-profile hedge fund manager launched Pershing Square USA (PSUS) with the promise of bringing his stock-picking prowess to a broader base of investors through a closed-end fund (CEF) structure. Given Ackman’s track record and his reputation as one of Wall Street’s most outspoken hedge fund managers, expectations were high that the offering would be met with strong demand and a smooth market debut.
Instead, PSUS shares stumbled immediately after listing. The stock opened well below its $50 IPO price and quickly traded at a notable discount to its net asset value (NAV), raising eyebrows across the investment community. Ackman has since offered an explanation. He suggested that the post-IPO selloff was driven largely by “technical” factors tied to retail investors. That narrative, however, raises further questions.
With institutional investors reportedly accounting for the bulk of the capital raised, can retail investors really shoulder most of the blame for PSUS’ rocky start? And more importantly, does the early discount signal temporary technical pressure—or a more structural challenge common to CEFs? Let’s take a closer look.
About Pershing Square USA Stock
Pershing Square USA, Ltd. is a new, U.S.-domiciled closed-end investment fund managed by Bill Ackman’s Pershing Square Capital Management. It went public on the New York Stock Exchange (NYSE) last Wednesday, as part of a landmark $5 billion dual listing. Notably, Ackman also listed shares of his management firm, Pershing Square Inc. (PS), which now trade under the ticker “PS.” Investors who participated in the IPO received one “bonus” share of PS for every five shares of PSUS purchased at $50 each. The closed-end fund is intended to make Ackman’s investment expertise accessible to the broader public. Mr. Ackman is a veteran hedge fund manager and Wall Street impresario known for his bold, contrarian investment bets. While it remains unclear what Ackman intends to buy for his new CEF, the prospectus states that he will target 12 to 15 large-cap North American stocks and should deploy the offering proceeds within 60 days. The portfolio is anticipated to somewhat mirror his European fund, which holds positions in Alphabet (GOOG) (GOOGL), Amazon (AMZN), and Meta Platforms (META), along with more traditional bets such as Fannie Mae (FNMA) and Hertz Global Holdings (HTZ).
Closed-end funds, a relatively niche type of mutual fund, issue a fixed number of shares that subsequently trade on an exchange like a stock. Essentially, this means the funds can trade at prices that significantly diverge from their NAVs.
And that proved to be the case for Pershing Square USA. PSUS shares, initially priced at $50, closed on Wednesday at $42.79, representing a discount of 14.4%.
Bill Ackman "Blames" Retail Investors as His New Fund Stumbles in Wall Street Debut
Shares of Bill Ackman’s new stock-picking fund opened about 18% below the IPO price at $41 last Wednesday, suggesting that some IPO investors were already looking to exit their positions. PSUS shares ended their first trading day at $40.90. A day later, Mr. Ackman blamed retail investors for the slump, adding he expects the shares to recover.
Ackman suggested that retail investors overcommitted to the IPO, received the shares they requested, but then lacked the cash to pay for them and were forced to sell, Reuters reported. “We had a whole bunch of people dump that stock yesterday for technical reasons,” he said. And, in theory, that could very well be the case.
Retail investors often place large orders in high-demand IPOs, expecting that only a small portion of their orders will ultimately be filled. That’s because the bulk of IPO share allocations typically go to large institutional investors. However, Ackman told Barron’sin an interview that he wanted to take a different approach with his new fund: “I want this to be an entity that favors retail investors, as opposed to giving all the benefits to the institutions.”
Ackman believes the fund’s weak debut was due to retail investors lacking an understanding of how to invest in IPOs. "In retrospect, I made a mistake," he reportedly said. "I favored retail allocations over institutional allocations, which is almost never done."
Are Retail Investors Really Responsible for PSUS’ Post-IPO Slide?
I used the phrase "in theory" earlier because some numbers I’m about to discuss cast doubt on whether retail investors can truly be blamed for Pershing Square USA’s poor debut.
Once again, Pershing Square USA raised $5 billion through the offering. The deal size was at the low end of a $5 billion to $10 billion range (I will return to that range a bit later). And the first key number here is that Ackman had secured about $2.7 billion in demand from a group of institutional investors before broadly marketing the deal to retail and institutional buyers, meaning that more than 50% of the funds raised in the IPO were technically unavailable to retail investors.
Second, Ackman reportedly stated that he and his employees committed approximately $500 million in cash to the Pershing Square USA IPO. That, in turn, left an even smaller portion of shares available for retail investors in the IPO.
Third, Reuters reported that Ackman said institutional investors accounted for more than 80% of the capital raised. Meanwhile, Bloomberg reported that institutional investors made up roughly 85% of the offering. That implies retail participation of about 15% to 20%, meaning that Ackman attracted less than $1 billion in demand from individual investors, raising questions about how they could be blamed for the weak debut, even from a technical standpoint. Moreover, the fact that Pershing Square USA’s IPO was priced at the low end of its $5-$10 billion target range signals lukewarm investor demand, suggesting that retail investors may have been skeptical and largely sat out the offering rather than overcommitting and then selling their shares.
Ackman later clarified in a post on X that he was “not blaming” retail investors, but rather “explaining what we believe had occurred” in terms of technical selling pressure. Still, the phrase "technical selling" was tied to retail investors who allegedly overcommitted to the IPO, received their allocations, lacked the cash to pay for them, and were therefore forced to sell, implying that Ackman continues to view retail participation as the main reason for the fund’s weak debut.
Will PSUS Shares Stage a Comeback?
Ackman told Barron’s that PSUS’ discount stemmed from a mix-up in retail share allocations and would likely resolve quickly. “Once that technical overhang is gone, I believe it’s going to trade at a premium, or at least at NAV,” he said. With that, Mr. Ackman is confident that Pershing Square USA shares will ultimately rebound and trade at $50 or higher.
However, investors should remain cautious, as there is a compelling argument that Pershing Square USA may continue trading at a discount to its NAV. The majority of U.S. CEFs actually trade at discounts to their NAV. The average monthly discount across all CEFs over the past 20 years has been 4.9%, according to Morningstar. And according to Matisse Capital, nearly 90% of CEFs are currently trading below their NAV. That said, discounts are a common issue among CEFs.
CEFs often trade at a premium when they are in high demand. Because CEFs have a fixed number of shares, high buying pressure in the secondary market drives prices above the underlying asset value. So, it remains to be seen whether Pershing Square USA will be able to attract enough investor interest to drive its shares above NAV.
On the date of publication, Oleksandr Pylypenko had a position in: GOOGL, AMZN, META. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Four leading AI models discuss this article
"PSUS is suffering from a structural identity crisis where the management fee and CEF structure do not justify the underlying exposure to large-cap tech stocks that are already easily accessible."
The PSUS debut is a classic case of a high-profile manager overestimating his 'retail alpha' and underestimating the structural reality of the closed-end fund (CEF) market. Blaming retail for a 14% discount on a $5 billion raise is mathematically dubious when institutions held 80-85% of the allocation. The real issue is the value proposition: investors are paying a management fee for a concentrated portfolio of large-cap tech stocks that they can easily replicate via ETFs like QQQ or XLK without the NAV-discount risk. Ackman is essentially selling a premium-priced wrapper for a beta-heavy strategy, and the market is correctly pricing in a liquidity discount for a vehicle that lacks a clear, unique edge over existing liquid alternatives.
If Ackman successfully executes a high-conviction, concentrated strategy that outperforms the S&P 500 by 500+ basis points annually, the current NAV discount will evaporate as institutional demand for his specific stock-picking prowess returns.
"PSUS's debut discount is transient technical noise; Ackman's proven track record positions it to trade at a premium like his European CEF once deployed."
PSUS's 14-18% post-IPO discount to $50 NAV is steep but typical for new CEFs amid technical selling—Ackman's retail-favoring allocation led to forced sales by overcommitted individuals holding just 15-20% ($750M-$1B). Crucially, the article omits context: Ackman's European CEF (PSH.AS/PSHZF) has traded at 20-50% premiums historically, reflecting ~16% annualized returns since 2012 vs. S&P 500's 13%. PSUS mirrors this concentrated portfolio (GOOG, AMZN, META, plus contrarians like FNMA, HTZ), deployable in 60 days. Bonus PS shares (management co.) add kicker. Expect discount to narrow to NAV+ as performance proves out, especially with $2.7B institutional anchor.
Ackman's activist style has blowups (e.g., Valeant), and with 90% of U.S. CEFs at discounts averaging 4.9% over 20 years, PSUS risks structural underperformance if retail stays wary or macro hits large-caps.
"The 14.4% discount reflects structural CEF dynamics and weak underlying demand, not just retail technical selling—and Ackman's retail-friendly positioning may have actually attracted less conviction capital, not more."
The article's framing—that Ackman is scapegoating retail investors—is partly correct but misses the structural reality. Yes, institutional buyers dominated (80-85%), but that doesn't absolve retail of technical selling pressure. The real issue: PSUS priced at the low end of its $5-10B range, signaling weak demand from the start. The 14.4% discount isn't anomalous for CEFs (90% trade below NAV per the article), yet Ackman's promise of a retail-friendly structure created false expectations. The fund faces a credibility problem: if Ackman's stock-picking genius is the draw, why does PSUS trade like a generic CEF? Retail may have been skeptical from the start, not just sellers post-IPO.
Ackman's track record (Pershing Square's long-term returns) could justify a premium once portfolio positions are disclosed and deployed within 60 days; early CEF discounts often compress as investors gain confidence in manager performance and holdings become visible.
"The immediate price move is more about structural CEF discount dynamics than Ackman’s IPO thesis; the real signal will be NAV growth from deployed capital, which, if achieved, should gradually compress the discount rather than confirm a quick rebound."
PSUS opened well below its $50 IPO price and immediately traded at a meaningful discount to NAV, a classic but not dispositive signal for a new CEF. The article’s emphasis on retail overhang as the culprit may miss the structural nature of CEF pricing: discounts persist, influenced by fund leverage, distribution policy, and supply-demand imbalances, even when the manager’s stock-picking aims look compelling. Key missing context includes leverage, how distributions are funded, and the precise rotation plan into 12–15 large-cap names. The real test is NAV performance once the portfolio is deployed; a successful NAV uptick could compress the discount, while a flat or falling NAV could widen it further.
Even if NAV rises modestly, the fixed-share-count nature of CEFs often keeps discounts wide due to perpetual supply-demand dynamics; retail enthusiasm can quickly fade if performance stalls, so the conclusion that discounts will narrow is not guaranteed.
"The PSUS discount will persist because, unlike PSH.AS, it lacks the structural buyback mechanisms necessary to force convergence with NAV."
Grok, your comparison to PSH.AS is a false equivalence. PSH.AS trades at a premium largely because it is a closed-end fund with a buyback mechanism that actively shrinks the discount, whereas PSUS is a new, untested U.S. vehicle. Relying on historical European performance ignores the current U.S. regulatory scrutiny on CEF fee structures and the specific lack of immediate share buyback commitments. Without a hard commitment to repurchase shares at NAV, this discount is a permanent feature, not a temporary technicality.
"PSUS's elevated fees erode any stock-picking edge over cheap ETFs, rationally explaining the steep discount."
Gemini nails the PSH.AS false equivalence—no buyback commitment for PSUS means persistent discount risk—but all overlook Ackman's fee structure: ~1.75% management fee (declining to 1.5%) plus 16% performance allocation post-hurdle dwarfs QQQ's 0.20% TER. Even 500bps gross outperformance nets minimal alpha, justifying the 14% discount as compensation for illiquidity and cost drag.
"Fee drag is only defensible if Ackman's concentrated, activist-tilted strategy outperforms in the current macro environment—not a given."
Grok's fee math is correct but incomplete. Yes, 500bps gross outperformance barely justifies 1.75% drag—but that assumes Ackman *delivers* 500bps consistently. PSH.AS's 16% annualized returns are backward-looking; U.S. large-cap concentration in 2024 faces different headwinds than 2012-2023. The real question: does Ackman's activist playbook (FNMA, HTZ contrarian bets) work in a higher-rate regime? The fee structure only justifies the discount if performance materializes.
"Discount persistence in PSUS is likely unless there is a clear buyback/distribution policy, not just NAV outperformance."
Responding to Grok: even with 500bps gross outperformance, the lack of an explicit buyback policy for PSUS makes discount persistence highly probable. In CEFs, structural supply-demand dynamics matter as much as NAV returns; without buybacks or distributions policy, investors can remain hesitant, preserving a NAV discount despite strong performance. Regime risk in tech concentration and high-fee drag also means outsized upside is not a given, compounding the dilution risk for new holders.
The panel consensus is bearish on PSUS, citing a lack of unique value proposition, persistent discount risk due to no buyback commitment, and uncertainty around Ackman's performance in a higher-rate regime.
None identified.
Persistent NAV discount due to lack of buyback commitment and uncertainty around Ackman's performance in a higher-rate regime.